hearing loss Cochlear Implant Outcomes Linked to Type of Genetic Diagnosis for Childhood Hearing Loss Data from more than 400 families affected by childhood-onset hearing loss indicated that specific genes and variants can provide prognostic clues, including success of cochlear implants. UK's NICE to Accelerate Assessment of Genedrive Test NICE plans to assess Genedrive's MT-RNR1 test for antibiotics-induced hearing loss in infants via a new program. ACMG Issues Updated Practice Guidelines for Hearing Loss Evaluations The update provides recommendations on how to approach genetic testing for individuals suspected of having syndromic or nonsyndromic hearing loss. UK Study Supports Clinical Adoption of Genedrive Newborn Hearing Loss Test Within NHS Premium The assay and point-of-care device were implemented in a trial in cooperation with clinical partners based at Manchester University NHS Foundation Trust. Orphan Gene Linked to Neurodevelopmental Disorder Characterized by Hearing Loss Through a sequencing screen of patients, researchers identified biallelic variants in SPATA5L1 that were associated with hearing loss, intellectual disability, and epilepsy. Sep 15, 2021 Sensorion, Sonova Partner for €7M Hearing Loss Genotyping Study Jul 13, 2021 Genedrive Expects CE-IVD Mark for POC SARS-CoV-2 Test by Fall; Advances Hearing Loss, HCV Assays Premium Jan 29, 2021 Invitae, Decibel Therapeutics Launch Free Testing Program for Congenital Hearing Loss Aug 26, 2020 Sequencing Could Augment Other Newborn Screening Approaches, NC NEXUS Study Finds Jul 7, 2020 Sequencing Study Reveals Role of RIPOR2 Mutation in Adult-Onset Hearing Loss Jan 27, 2020 UK Newborn Trial to Assess PCR Test for Antibiotic-Induced Hearing Loss Sep 27, 2019 Hearing Loss GWAS of UK Biobank Samples Implicates More Than 40 Loci Aug 23, 2019 Genedrive Prepping for UK Commercial Launch of PGx Test for Neonatal Hearing Loss Premium Jun 12, 2019 BGI Genomics Continues to Grow Clinical Testing Business, Add Partnerships Premium Nov 30, 2018 FDA Clears Meridian Bioscience's Newborn Cytomegalovirus Test Oct 19, 2018 ASHG: Australian Newborn WES Project Combines Hearing Loss Dx With Optional Secondary Results Aug 23, 2018 U of Miami Medicine Wins $3M NIH Grant for Hearing Loss Genetics Research Jun 20, 2018 Genedrive Receives UK NIHR Grant for Antibiotic-Related Hearing Loss Assay Apr 11, 2018 Newborn Screening for Hearing Loss Might Benefit From Genomic Testing Premium Jun 20, 2016 Genetic Newborn Screen IDs Children With Progressive Hearing Loss That Conventional Screen Missed Feb 9, 2015 GWAS Unearths Loci Linked to Hearing Loss Risk After Cisplatin Chemotherapy Feb 9, 2012 Quark Still Sees IPO as a Possibility as Phase II Trials Near Completion Premium Jun 15, 2011 Partners HealthCare Center's LMM to Introduce Clinical Whole-Genome Sequencing Interpretation Service in 2012 Premium Nov 16, 2010 Targeted High-Throughput Sequencing Used for Hereditary Hearing Loss Genetic Testing Breaking News New Products Posted to GenomeWeb: Qiagen, Thermo Fisher, Bionano Genomics, BillionToOne, More People in the News at Illumina Ventures, Element Biosciences, Epigenomics, Exagen, More Genomic Approaches Boost Rare Disease Diagnoses in Middle Eastern Patient Population GeneDx to Raise $150M in Public and Direct Stock Offerings In Brief This Week: T2 Biosystems, Novacyt, OpGen, Dante Genomics, Nautilus Biotechnology, More The Scan Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups. Genome-Wide Analysis Sheds Light on Genetics of ADHD A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder. MicroRNA Cotargeting Linked to Lupus A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus. Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.